Tag: SoniVie
Boston Scientific to acquire renal denervation technology developer SoniVie
Boston Scientific has entered into a definitive agreement to acquire SoniVie Ltd, a privately held medical device company that has developed the TIVUS intravascular...
SoniVie appoints veteran medtech executive Raymond W Cohen as chairman of...
SoniVie Ltd. announced today the appointment of Raymond W Cohen to serve as its chairman of the board of directors.
Cohen has served as the...
SoniVie announces successful procedure with Tivus system on first patient enrolled...
SoniVie today announced that on 30 May this year the first patient was treated with its renal artery denervation Tivus therapeutic intravascular ultrasound technology, as...
SoniVie receives FDA IDE approval for pilot study to treat hypertension...
SoniVie recently announced that on 5 May 2022 the US Food and Drug Administration (FDA) granted investigational device exemption (IDE) approval for its REDUCED1...